Analogs of Substance P modified at the C-terminus which are both agonist and antagonist of the NK-1 receptor depending on the second messenger pathway.
The initial goal of this study was to analyze, using photolabeling, the interactions between Substance P and its tachykinin NK-1 receptor. Therefore, the photoreactive amino acid para-benzoyl-phenylalanine (pBzl)Phe was incorporated into the Substance P sequence from position 4 to 11 leading to Bapa0[(pBzl)Phex]SP analogs. Biotinyl sulfone-5-aminopentanoic acid (Bapa) was introduced in order to purify the covalent complex. These photoreactive SP analogs were first assayed for their affinity for the two binding sites associated with the NK-1 receptor, as well as for their potency in activating the phospholipase C and adenylate cyclase pathways. All analogs photoreactive from position 4 to 11 have moderate to high affinity for the two NK-1 receptor-binding sites, except for the analog modified at position 7. This affinity could be correlated to their potency to activate the phospholipase C and adenylate cyclase pathways, except for the analog photoreactive at position 11. Bapa0[(pBzl)Phe11]SP was found to be an agonist in the phospholipase C pathway and an antagonist in the adenylate cyclase pathway, other analogs modified at position 11 were therefore analyzed. Among these, Bapa0[Pro9, (pBzl)Hcy(O2)11]SP is a partial agonist, whereas Bapa0[Hcy(ethylaminodansyl)11]SP is a full agonist in the phospholipase C pathway, the two analogs being antagonist in the adenylate cyclase pathway. These results show that analogs of SP can be simultaneously agonist at one binding site and antagonist at the other binding site associated with the NK-1 receptor.
Sachon
E
E
Structure et Fonction de Molécules Bioactives, Université Pierre et Marie Curie, Paris, France.
Girault-Lagrange
S
S
Chassaing
G
G
Lavielle
S
S
Sagan
S
S
D000262:Adenylyl Cyclases / Q000096:biosynthesis; D000818:Animals; D016466:CHO Cells; D006224:Cricetinae; D006801:Humans; D013058:Mass Spectrometry; D064729:Neurokinin-1 Receptor Antagonists; D010740:Phospholipases / Q000378:metabolism; D019920:Photoaffinity Labels; D018040:Receptors, Neurokinin-1 / Q000819:agonists* / Q000378:metabolism; D015290:Second Messenger Systems; D013373:Substance P / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000494:pharmacology*
D064729:Neurokinin-1 Receptor Antagonists; D019920:Photoaffinity Labels; D018040:Receptors, Neurokinin-1; D013373:Substance P; D010740:Phospholipases; D000262:Adenylyl Cyclases